Success Story: Improving Outcomes for Inflammatory Bowel Disease Patients Leads to NIW Approval

Posted by wegreened on July 28, 2026 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

"Thank you so much, that's great news and huge relief. It's been a pleasure working with you as well. This was not a straightforward case, but your team made it very simple and easy for me.”

On June 2^nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Hospitalist and Assistant Professor in the Field of Medicine (Approval Notice).

General Field: Medicine

Position at the Time of Case Filing: Hospitalist and Assistant Professor

Country of Origin: Pakistan

State of Residence at the Time of Filing: Rhode Island

Approval Notice Date: June 2^nd, 2026

Processing Time: 14 months, 12 days (Premium Processing Requested)

Case Summary:

A hospitalist and assistant professor from Pakistan sought assistance from North America Immigration Law Group (Chen Immigration Law Associates) in pursuing an NIW petition based on his work in medicine and clinical outcomes research.

The petition presented his proposed endeavor as a practical effort to improve patient care through retrospective and cross-sectional studies. By identifying risk factors that placed certain groups of patients at higher risk for complications, hospitalization, and increased healthcare utilization, his research aimed to support earlier intervention strategies and more effective allocation of healthcare resources.

The client brought a combination of clinical and research experience to this endeavor. He held an M.B.B.S. degree and had completed medical training and clinical practice across multiple healthcare settings.

His scholarly record included:

10 peer-reviewed journal articles and 10 conference abstracts

48 citations

1 publication ranked among the top 10% most-cited Clinical Medicine articles for its publication year

To satisfy strict regulatory thresholds for national importance and substantial merit, the petition framed the client's clinical research as a vital mechanism for reducing the systemic and economic burdens of high-prevalence chronic diseases. By pairing evidence of extensive downstream replication by independent medical teams with a narrative focused on healthcare cost-reduction and optimized risk-stratification, the filing established a clear record of non-speculative, nationwide utility. The strategic argument demonstrated that his predictive models directly strengthened domestic public health infrastructure and optimized institutional healthcare resource allocation.

Following a Premium Processing upgrade requested on April 13th, 2026, USCIS approved the I-140 NIW petition on June 2nd, 2026. Ultimately, this approval recognized the value of continued research focused on improving outcomes for patients with inflammatory bowel disease and advancing evidence-based approaches to gastrointestinal care in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%